Estimating Blood Volume Loss With Wireless, Wearable Ultrasound: A Pilot Investigation
Jon-Emile S Kenny, Melissa Hebscher, Tracy Savery, Sarah Atwi, Daniel Lachner-Piza, Andrew M Eibl, Joseph K Eibl, Soumya Vungarala, Niki M Dietz, Chul-Ho Kim, Bruce D Johnson · 2026
Read Estimating Blood Volume Loss With Wireless, Wearable Ultrasound: A Pilot Investigation by Jon-Emile S Kenny, Melissa Hebscher, Tracy Savery, Sarah Atwi, Daniel Lachner-Piza, Andrew M Eibl, Joseph K Eibl, Soumya Vungarala, Niki M Dietz, Chul-Ho Kim, Bruce D Johnson (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13445608.txt.
Introduction
Kenny and colleagues pilot a wearable ultrasound device for estimating blood loss in this 2026 study. Detecting hemorrhage early is critical, yet blood volume loss is hard to measure directly. The team relied on a physiological chain: as blood volume falls, stroke volume falls, and a corrected flow time in the carotid artery shortens in step. Healthy volunteers wore a wireless Doppler patch on the neck while donating blood under supervision.
Twenty donors gave an average of about 414 milliliters of blood, roughly nine percent of their blood volume, across more than 46,000 recorded heartbeats. The relationship between volume lost and the change in flow time was strong and linear. Each millisecond of shortening corresponded to about a 0.4 percent drop in blood volume. That figure comes from their regression model. Validation in trauma patients is now underway, the team reports.
Catalog record
| CREATOR | Jon-Emile S Kenny, Melissa Hebscher, Tracy Savery, Sarah Atwi, Daniel Lachner-Piza, Andrew M Eibl, Joseph K Eibl, Soumya Vungarala, Niki M Dietz, Chul-Ho Kim, Bruce D Johnson |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Estimating Blood Volume Loss With Wireless, Wearable Ultrasound: A Pilot Investigation Authors: Jon-Emile S Kenny, Melissa Hebscher, Tracy Savery, Sarah Atwi, Daniel Lachner-Piza, Andrew M Eibl, Joseph K Eibl, Soumya Vungarala, Niki M Dietz, Chul-Ho Kim, Bruce D Johnson Published: 2026 ABSTRACT AbstractIntroductionDetecting and estimating blood volume loss are important for the diagnosis and management of life-threatening hemorrhage. There is a direct relationship between percent blood volume loss (BVL%) and falling in stroke volume (SV); furthermore, there is a direct relationship between diminishing SV and the corrected flow time of the carotid artery (ccFT). Therefore, we hypothesized that change in ccFT (ccFTΔ) would directly relate with BVL% in a phlebotomy paradigm.Materials and MethodsA prospective, convenience sample of healthy volunteers was studied. Volunteers underwent blood donation protocol in a physiology lab. A wireless, wearable Doppler ultrasound system monitored ccFT during blood donation. Traditional vital signs were also measured throughout. The relationship between traditional vital signs as well as ccFTΔ were compared to BVL% using 2 mixed linear regression models.ResultsData from 20 subjects and blood donations comprising 46,123 cardiac cycles are included. On average 413.5 ± 39 mL of blood were drawn representing 8.6 ± 1.6% BVL%. There was a significant and strong linear relationship between BVL% and ccFTΔ during blood draw with the regression slope demonstrating that for every 1 ms reduction in ccFT there was a 0.4% reduction in blood volume.ConclusionsIn healthy subjects and when blood loss is the sole mechanism for falling SV, we estimate that for every 1 ms reduction in ccFT, there is an approximate 0.4 BVL%. Validation of these results in patients with traumatic hemorrhage is underway. INTRODUCTION Detecting traumatic blood loss is traditionally accomplished via clinical history and vital signs,1 though point of careultrasound imaging is increasingly used.2 Yet, without ultrasound image supplementation, vital signs alone are generally insensitive for diagnosing cryptic hemorrhage and only weakly relate with percent blood volume loss (BVL%).1 Estimating BVL% is clinically challenging with numerous research techniques available but few easily applied to patients with acute traumatic injuries.3 Therefore, an objective assessment of BVL%, especially monitored over time, could help triage and treat patients with life-threatening hemorrhage. We have previously described a novel, wireless, and wearable continuous wave Doppler ultrasound that continuously measures surrogates of SV in the common carotid artery.4-8 Using this new ultrasound technology, we have shown that a 10% fall in stroke volume (SV) correlates with a 5- to 10-ms reduction in the corrected flow time of the common carotid artery (ccFT).9-11 Furthermore, it has been shown that BVL% can be estimated as approximately one-half the percent fall in SV during models of central hypovolemia and exsanguination.12 Given these previously reported values, we hypothesized that for every 0.25 to 0.5% reduction in blood volume (i.e., 0.25-0.5 BVL%), ccFT would fall, on average, by 1 ms. To test this hypothesis, we measured the change in ccFT (ccFTΔ) and BVL% during phlebotomy of healthy volunteers. MATERIALS AND METHODS Clinical Setting The Research Ethics Board of the Mayo Clinic approved this study. A convenience sample of adult patients recruited by a physiology laboratory comprise this analysis. Exclusion criteria were: blood donation within 112 days, hemoglobin <13.0 g/dL for men and <12.0 g/dL for women, under the age of 18 or over 50, systolic blood pressure <90 mm Hg or >180 mm Hg, diastolic blood pressure >100 mm Hg, current smokers, BMI >38 kg/m2, known or planned pregnancy. Blood Donation and Blood Volume Estimation Subjects remained in the sitting position in a blood donation chair. Subjects underwent blood draw procedure. Blood was removed slowly into a blood bag over 8 to 12 minutes (approximately 50 mL/min) via a 16- or 18-gauge intravenous catheter. The blood volume withdrawn was not to exceed 13% of whole blood volume with a maximum withdrawal of 450 mL ±10%. The subject’s whole blood volume was estimated by the equation of Nadler et al.13 Physiological Monitoring A wearable Doppler ultrasound system (Flosonics Medical, Sudbury, Canada) was placed on the neck over the common carotid artery.9 In all subjects the common carotid Doppler pulse was detected by placing the device adjacent to the thyroid cartilage and moved laterally until a displayed spectrogram and audible Doppler shift consistent with the common carotid artery was obtained; then the wearable device was adhered in place using its incorporated adhesive. Data from the device is transmitted via Bluetooth to an iOS graphical interface. The ccFT was determined by Wodey’s equation as: where flow time is the duration of systole in seconds and heart rate is 60/cycle length (Figure 1B). (A) The wireless Doppler ultrasound in place on a patient’s neck. The device is placed over the common carotid artery and internal jugular vein and communicates wirelessly with a nearby tablet. (B) Example of carotid Doppler spectrogram as it appears in the graphical user interface. Features from the device used to calculate ccFT using Wodey’s equation and labeled in white. In addition to the wearable ultrasound, the Nexfin, finger-cuff, non-invasive hemodynamic monitor (Edwards Lifesciences, Irvine, CA, United States) was worn to measure continuous vital signs throughout the entire blood draw. Baseline values were recorded over a 2-minute period before beginning blood draw. Continuous monitoring persisted through the blood draw and for an additional 5 minutes, post-procedure. Data Alignment and Preprocessing Carotid Doppler and Nexfin hemodynamic data were temporally aligned to ensure accurate synchronization for analysis. Alignment was performed by calculating the time shift with the greatest correlation between carotid Doppler and Nexfin heart rate for each subject. Doppler and Nexfin data were then examined for outliers in ccFT, heart rate, Nexfin stroke volume (SV), and Nexfin mean arterial pressure (MAP). Outliers were identified and excluded based on being more than 2 standard deviations from the subject’s own mean, for each variable of interest. Our analysis reflects the underlying trend during a gradual 8 to 12 minute blood draw rather than single cardiac cycle fluctuations. To mitigate beat-to-beat variability, respiratory variability, and potential measurement noise, a rolling mean smoothing filter of 30 cardiac cycles was then applied to the cleaned data to reduce cycle-to-cycle variability. Percent blood volume loss (BVL%) was estimated by dividing the total volume of blood withdrawn for each subject by their estimated total blood volume. Total blood volume was estimated based on sex, height, and weight using Nadler et al’s formula13 (Men: Blood Volume = [0.3669 × Height3] + [0.03219 × Weight] + 0.6041; Women: Blood Volume = [0.3561 × Height3] + [0.03308 × Weight] + 0.1833). Within the blood draw period, cumulative BVL% over time was calculated by distributing the total BVL% proportionally across the duration of the blood draw, assuming a constant rate of withdrawal. Change in ccFT (ccFTΔ) was computed as the difference between the baseline average and each time point during blood draw. Change in MAP (MAPΔ) and stroke volume (SVΔ) from Nexfin were calculated in the same way, as the difference between the baseline average and the value at each time point during blood draw. Statistical Analysis Change in traditional vital signs as well as ccFTΔ, were compared to BVL% using mixed-effects linear regression models. The first model assessed whether ccFTΔ predicted BVL% at the subject level, with BVL% as the dependent variable, ccFTΔ as